Standing Order
Intellia Therapeutics, Inc.

Dashboard

Intellia Therapeutics, Inc.

NTLANASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$1.7B
Price$12.3352w $7.16 – $27.98
Conviction3/ 5
Revenue (TTM)$60M
Revenue growth YoY+12.6%
P/E (trailing)—
Gross margin-46.5%
Operating margin-711.7%
Net margin-672.2%
52w price change+72.2%
Next earningsNov 5, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Sep 8
    OtherSEC

    Intellia Therapeutics filed Form 8-K on 2026-09-08 covering items 7.01, 8.01 and 9.01.

  • Sep 4
    DealSEC

    8-K filed with items 1.01, 2.03, 7.01, 9.01 disclosing material definitive agreement and financial obligation.

  • Aug 24
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Aug 6
    Financial resultsSEC

    Intellia Therapeutics filed 8-K (items 2.02, 9.01) reporting financial results.

  • Jul 24
    Ownership changeSEC

    SEC Form 4 filing reporting change in beneficial ownership by insider.

  • Jul 6
    Ownership changeSEC

    SEC Form 4 filing reporting change in beneficial ownership.

  • Jul 6
    Ownership changeSEC

    SEC Form 4 insider beneficial ownership change filing.

  • Jun 15
    OtherSEC

    SEC 8-K filing (items 7.01, 8.01, 9.01)

  • Jun 10
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership.

  • Jun 10
    Ownership changeSEC

    SEC Form 4 filing reporting change in beneficial ownership by NTLA insider.

  • Jun 10
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jun 10
    OtherSEC

    8-K item 5.07 filing on results of matters submitted to shareholder vote.

  • Jun 10
    Ownership changeSEC

    SEC Form 4 filing for insider ownership transaction

  • Jun 10
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jun 10
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership.

  • Jun 10
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • May 11
    Financial resultsSEC

    8-K filing (items 2.02, 9.01) disclosing financial results.

Not financial advice — research and opinion only. Disclosures